PR NEWSWIRE

Previous Stories

Prospection partners with leading Japanese healthcare data provider Medical Data Vision to improve treatment access for patients

Sep 06 2022 - PR NewsWire

SYDNEY, Sept. 6, 2022 /PRNewswire/ — Health analytics pioneer, Prospection has announced a unique global data access agreement with leading…


Nintex Appoints Jon “Jet” Theuerkauf as its new Chief Customer Officer

Sep 06 2022 - PR NewsWire

Company appoints industry exec to lead customer advocacy programs and professional services MELBOURNE, Australia, Sept. 6, 2022 /PRNewswire/ — Nintex,…


OrionVM and ELO Digital Office Australia Launch New Cloud Solution for Enterprise Content Management

Sep 05 2022 - PR NewsWire

New IaaS partnership with OrionVM delivers secure, scalable and fast performing cloud environments for ELO’s ECM customers SYDNEY, Sept. 5,…


Homely releases FY22 results, announces 58% annualised revenue growth, strengthening industry support.

Sep 05 2022 - PR NewsWire

MELBOURNE, Australia, Sept. 5, 2022 /PRNewswire/ –  Highlights from Homely’s full year results Revenue increased 58% YoY 49% revenue growth…


Sungrow To Supply Australia’s Largest DC-coupled Solar plus Storage Project with its Liquid-Cooled ESS PowerTitan

Sep 05 2022 - PR NewsWire

SYDNEY, Sept. 5, 2022 /PRNewswire/ — Sungrow, the global leading inverter and energy storage solution provider for renewables, announced that…


TrafficGuard Extends Ad Protection to Facebook Ads with “TrafficGuard Social”

Sep 05 2022 - PR NewsWire

PERTH, Australia, Sept. 5, 2022 /PRNewswire/ – Leading omnichannel digital ad verification and fraud prevention platform, TrafficGuard, today launched TrafficGuard Social,…


Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

Sep 05 2022 - PR NewsWire

– CornerStone-001(NCT05163223), the multiregional clinical trial for breast cancer treatment, received U.S. FDA approval for Phase 2 trial following the approvals in Australia and…


LEADERS IN NUTRITIONAL MEDICINE ON CUSP OF BREAKTHROUGH GUIDELINES TO TACKLE LONG-COVID SYMPTOMS

Sep 05 2022 - PR NewsWire

Guidelines for health practitioner diagnosis of Long-COVID are in review Understanding of mitochondrial health integral to post-pandemic recovery, say experts…


Sims Limited Appoints Philip Bainbridge to Board of Directors

Sep 01 2022 - PR NewsWire

– Independent Non-Executive Director fills casual vacancy on the Board – SYDNEY, Sept. 1, 2022 /PRNewswire/ — Sims Limited, a…


Airwallex finds Aussie businesses charging ahead with global expansion

Sep 01 2022 - PR NewsWire

Despite economic challenges, 69 per cent of Australian SMEs plan to be operating outside Australia by 2027 42 per cent…


Analyse The Market From A Different Angle